The Determination of Chloroquine Resistent Falciparum Malaria in Nimbora, Iri…

Edition

-

ISBN/ISSN

-

Collation

8 p.

Series Title

-

Call Number

EKO 1979 8

Efficacy of Chloroquine, Chloroquine Plus Sulphadoxine-Pyrimethamine, and Amo…

Plasmodium vivax malaria resistant to chloroquinenis alarming in Indonesia and has been also reported in other countries. An alternative drug is needed. The study was a prospective evaluation and a comparative study of the therapeutic efficacy of choloquine 25 mg base/kg bw for 3 days (CQ3 plus sulfadoxine-pyrimethamine based on pyrimethamine of 1.23 mg/kg bw single dose (SPI) [CQ3=SPI, n=84] a…

Sensitivity studies of plasmodium falciparum to chloroquine and other antimal…

Edition

-

ISBN/ISSN

-

Collation

19 p.

Series Title

-

Call Number

308 EKO

Reaksi kekebalan tubuh hunoral pada penderita plasmodium falciparum dan P. V…

Edition

-

ISBN/ISSN

-

Collation

15 p.

Series Title

-

Call Number

221/222 PMR

Eksplorasi mutu dan uji bioekivalensi tablet klorokuin dalam pengobatan malaria

Edition

-

ISBN/ISSN

-

Collation

24 p.

Series Title

-

Call Number

433A/433B FAR

Pengembangan Teknologi Farmasi Klorokuin Menuju Efek Samping yang Lebih Renda…

Edition

-

ISBN/ISSN

-

Collation

13 p.

Series Title

-

Call Number

439 A+B

Penggunaan Genotyping untuk Menentukan Resistensi Parasit terhadap Obat Antim…

Edition

-

ISBN/ISSN

-

Collation

12 p.

Series Title

-

Call Number

65 P5

Clinical Trials of Artesunate and Artemether against Falciparum Malaria in Ch…

At present quinine is the antimalaria drug of choice in the treatment of chloroquine or multidrug resistant malaria and severe or complicated malaria. Artemisinine, a new antimalarial has been reported to be highly effective and of low toxicity. Therefore, artemisinine derivates (artesunate and artemether) need to be evaluated to have an alternative drug to be used in Indonesia. The study has b…

In Vivo Survey of Resistance Chloroquine by Plasmodium falciparum at Oksibil,…

Resistance to chloroquine by Plasmodium falciparum in the Oksibil region of Irian Jaya was evaluated by in vivo testing in July 1994 among 44 patients. Study subjects ranged in age from 5 to 42 years. At day 7 of the test 10 subjects (23 percent) had persistent or recurrent asexual parasitemias. Among these infections, 8 were classified RII and 2 RIII levels of resistance on the basis of the po…

In Vivo Survey of Resistance Chloroquine by Plasmodium falciparum at Oksibil,…

Resistance to chloroquine by Plasmodium falciparum in the Oksibil region of Irian Jaya was evaluated by in vivo testing in July 1994 among 44 patients. Study subjects ranged in age from 5 to 42 years. At day 7 of the test 10 subjects (23 percent) had persistent or recurrent asexual parasitemias. Among these infections, 8 were classified RII and 2 RIII levels of resistance on the basis of the po…